Grapefruit USA Inc (GPFT)

[borntwice]

SANO (or anyone else that knows)

Do you know if it is possible through FOIA to receive previous correspondence from the FDA, including the requests for additional information?

I'd like to see how that information lines up with what we were told on other conference calls, particualrly the one where the CEO insisted it was only a "labeling issue." Given the fact of the NSE, it seems impossible that it was only a "labeling issue"

I'd be willing to spring for the information and would definitley post it when I received it. I'm particularly interested in the previous three correspondence letters from the FDA prior to the NSE as we were given very specific information on conferecne calls as to what the FDA was doing / saying at those times that all seems to fly in the face of the NSE.

Thanks in advance